中重度与重度ARDS患者无体外循环下超低潮气量通气的可行性与安全性
本研究为多中心非实验性前后对照研究,纳入35例PaO2/FiO2≤150 mmHg、ARDS诊断24小时内的患者。入组后将潮气量降至4 ml/kg并维持pH≥7.20,呼吸频率增至最高40次/分,PEEP按PEEP-FiO2表设定。主要终点第2天驱动压较入组时从12 [9-15] cmH2O显著降至8 [6-11] cmH2O,潮气量从6.0 [5.9-6.1]降至4.1 [4.0-4.7] ml/kg。第2天65%患者潮气量<4.2 ml/kg,88%<5.25 ml/kg;2例(6%)出现急性肺心病,11例(32%)出现pH<7.15的一过性重度酸中毒,14例(41%)第90天前死亡。作者认为超低潮气量通气可能用于约2/3中重度至重度ARDS患者。
要点
- 35例PaO2/FiO2≤150 mmHg的ARDS患者入组后将潮气量降至4 ml/kg并维持pH≥7.20,呼吸频率最高增至40次/分。
- 第2天驱动压从12 [9-15]降至8 [6-11] cmH2O,中位下降4 cmH2O,潮气量从6.0 [5.9-6.1]降至4.1 [4.0-4.7] ml/kg。
- 第2天65% [95%CI 48%-79%]患者潮气量<4.2 ml/kg,88% [95%CI 74%-95%]<5.25 ml/kg。
- 11例(32%)出现pH<7.15的一过性重度酸中毒,2例(6%)入组后发生急性肺心病,14例(41%)第90天前死亡。
- 作者认为超低潮气量通气可能用于约2/3中重度至重度ARDS患者,代价是约1/3患者出现一过性重度酸中毒。
适用人群与场景
- ARDS患者,PaO2/FiO2≤150 mmHg,ARDS诊断24小时内入组。
诊断标准与关键阈值
- ARDS诊断后24小时内入组,PaO2/FiO2≤150 mmHg。
- 潮气量降至4 ml/kg后按pH≥7.20调整,允许呼吸频率增至最高40次/分。
- PEEP按PEEP-FiO2表设定。
处置流程与药物剂量
- 入组后将潮气量降至4 ml/kg,再根据pH≥7.20进一步调整。
- 呼吸频率增至最高40次/分以维持pH≥7.20。
- PEEP按PEEP-FiO2表设定。
红旗征与不能漏的情况
- 入组后2例(6%)发生急性肺心病。
- 11例(32%)出现pH<7.15的一过性重度酸中毒。
研究设计与关键结果
- 多中心非实验性前后对照研究,35例PaO2/FiO2≤150 mmHg的ARDS患者,入组后潮气量降至4 ml/kg并维持pH≥7.20。
- 主要终点第2天驱动压较入组时从12 [9-15]降至8 [6-11] cmH2O,显著下降。
- 潮气量从6.0 [5.9-6.1]降至4.1 [4.0-4.7] ml/kg。
- 第2天65% [95%CI 48%-79%]患者潮气量<4.2 ml/kg,88% [95%CI 74%-95%]<5.25 ml/kg。
- 2例(6%)入组后发生急性肺心病,11例(32%)出现pH<7.15的一过性重度酸中毒,14例(41%)第90天前死亡。
证据类型、等级与局限
- 证据类型:多中心非实验性前后对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为超低潮气量通气可能用于约2/3中重度至重度ARDS患者,驱动压中位下降4 cmH2O,代价是约1/3患者出现一过性重度酸中毒。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Mechanical ventilation with ultra-low tidal volume (VT) during ARDS may reduce alveolar strain, driving pressure and hence ventilator-induced lung injury, with the main drawback of worsening respiratory acidosis. We hypothesized that VT could be reduced down to 4 ml/kg, with clinically significant decrease in driving pressure, without the need for extracorporeal CO2 removal, while maintaining pH > 7.20.
METHODS: We conducted a non-experimental before-and-after multicenter study on 35 ARDS patients with PaO2/FiO2 ≤ 150 mmHg, within 24 h of ARDS diagnosis. After inclusion, VT was reduced to 4 ml/kg and further adjusted to maintain pH ≥ 7.20, respiratory rate was increased up to 40 min-1 and PEEP was set using a PEEP-FiO2 table. The primary judgment criterion was driving pressure on day 2 of the study, as compared to inclusion.
RESULTS: From inclusion to day 2, driving pressure decreased significantly from 12 [9-15] to 8 [6-11] cmH2O, while VT decreased from 6.0 [5.9-6.1] to 4.1 [4.0-4.7] ml/kg. On day 2, VT was below 4.2 ml/kg in 65% [CI95% 48%-79%], and below 5.25 ml/kg in 88% [CI95% 74%-95%] of the patients. 2 patients (6%) developed acute cor pulmonale after inclusion. Eleven patients (32%) developed transient severe acidosis with pH < 7.15. Fourteen patients (41%) died before day 90.
CONCLUSION: Ultra-low tidal volume ventilation may be applied in approximately 2/3 of moderately severe-to-severe ARDS patients, with a 4 cmH2O median reduction in driving pressure, at the price of transient episodes of severe acidosis in approximately 1/3 of the patients.
参考来源
- Richard JC, Marque S, Gros A, et al. Feasibility and safety of ultra-low tidal volume ventilation without extracorporeal circulation in moderately severe and severe ARDS patients. Intensive Care Med. 2019. PMID: 31549225. doi:10.1007/s00134-019-05776-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。